1. Home
  2. IFS vs RYTM Comparison

IFS vs RYTM Comparison

Compare IFS & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercorp Financial Services Inc.

IFS

Intercorp Financial Services Inc.

HOLD

Current Price

$57.79

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$96.09

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFS
RYTM
Founded
1897
2008
Country
Peru
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.8B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
IFS
RYTM
Price
$57.79
$96.09
Analyst Decision
Buy
Strong Buy
Analyst Count
1
14
Target Price
$48.00
$131.14
AVG Volume (30 Days)
373.1K
555.5K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
28.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$55.34
Revenue Next Year
$7.38
$86.06
P/E Ratio
$9.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.39
$60.99
52 Week High
$57.10
$122.20

Technical Indicators

Market Signals
Indicator
IFS
RYTM
Relative Strength Index (RSI) 70.08 63.16
Support Level $43.65 $82.43
Resistance Level N/A $100.69
Average True Range (ATR) 1.96 4.45
MACD 0.76 0.65
Stochastic Oscillator 99.36 83.20

Price Performance

Historical Comparison
IFS
RYTM

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: